High-Throughput Regulatory Part Prototyping and Analysis by Cell-Free Protein Synthesis and Droplet Microfluidics.
ACS Synth Biol
; 11(6): 2108-2120, 2022 06 17.
Article
in En
| MEDLINE
| ID: mdl-35549070
Engineering regulatory parts for improved performance in genetic programs has played a pivotal role in the development of the synthetic biology cell programming toolbox. Here, we report the development of a novel high-throughput platform for regulatory part prototyping and analysis that leverages the advantages of engineered DNA libraries, cell-free protein synthesis (CFPS), high-throughput emulsion droplet microfluidics, standard flow sorting adapted to screen droplet reactions, and next-generation sequencing (NGS). With this integrated platform, we screened the activity of millions of genetic parts within hours, followed by NGS retrieval of the improved designs. This in vitro platform is particularly valuable for engineering regulatory parts of nonmodel organisms, where in vivo high-throughput screening methods are not readily available. The platform can be extended to multipart screening of complete genetic programs to optimize yield and stability.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Microfluidics
/
High-Throughput Screening Assays
Language:
En
Journal:
ACS Synth Biol
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United States